ProfileGDS4132 / 206494_s_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 8% 7% 8% 7% 7% 6% 6% 7% 7% 6% 3% 5% 7% 4% 2% 3% 4% 5% 5% 3% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10116.04598
GSM201543Muscle PCOS pioglitazone 12113.96177
GSM201544Muscle PCOS pioglitazone 16116.46448
GSM201545Muscle PCOS pioglitazone 20115.73577
GSM201829Muscle PCOS pioglitazone 23115.65347
GSM201830Muscle PCOS pioglitazon 25115.01386
GSM201831Muscle PCOS pioglitazone 27114.71896
GSM201832Muscle PCOS pioglitazone 3116.50837
GSM201833Muscle PCOS pioglitazone 4114.21427
GSM201834Muscle PCOS pioglitazone 8113.83456
GSM201835Muscle PCOS after pioglitazone 1029.989973
GSM201836Muscle PCOS after pioglitazone 12211.03485
GSM201837Muscle PCOS after pioglitazone 16211.60717
GSM201838Muscle PCOS after pioglitazone 20210.07354
GSM201839Muscle PCOS after pioglitazone 23210.55992
GSM201840Muscle PCOS after pioglitazone 2529.430333
GSM201841Muscle PCOS after pioglitazone 27211.47514
GSM201842Muscle PCOS after pioglitazone 329.980755
GSM201843Muscle PCOS after pioglitazone 4211.81745
GSM201844Muscle PCOS after pioglitazone 8210.00233